跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gitrabin lyophilisate for solution for infusion 200mg/vial - HSA Drug Approval Details
Approvals
/
HSA
/
Gitrabin lyophilisate for solution for infusion 200mg/vial
Approved
THERAPEUTIC
Gitrabin lyophilisate for solution for infusion 200mg/vial
S.C. Sindan-Pharma S.R.L (ROMANIA)Actavis Italy S.P.A (ITALY)
🇸🇬 Health Sciences Authority
Approval Date
May 14, 2010
Approval ID
250bf1ed397e4ed5
Company
S.C. Sindan-Pharma S.R.L (ROMANIA)Actavis Italy S.P.A (ITALY)
Type
Therapeutic
Approval Details
Approval Id
250bf1ed397e4ed5
Drug Name
Gitrabin lyophilisate for solution for infusion 200mg/vial
Product Name
Gitrabin lyophilisate for solution for infusion 200mg/vial
Approval Number
SIN13799P
Approval Date
2010-05-14
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
L01BC05
Atc Item Name
gemcitabine
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Active Ingredients
Gemcitabine hydrochloride 228.0 mg eqv gemcitabine
200 mg
GEMCITABINE HYDROCHLORIDE 228 MG EQV GEMCITABINE
200 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 14, 2010
Approval ID
250bf1ed397e4ed5
Type
Therapeutic
Back to HSA Approvals
